Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 374-378

  Martin, Mary E ^a   Bunnell, Joseph E ^b   Dumler, J Stephen ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CYTOKINE PRODUCTION; EHRLICHIOSIS; FEMALE; FEVER; HOST RESISTANCE; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; LIVER INJURY; MOUSE; NONHUMAN; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; EHRLICHIOSIS; FEMALE; GRANULOCYTES; HISTIOCYTES; INTERFERON TYPE II; INTERLEUKIN-10; LIVER; LYMPHATIC SYSTEM; MICE; MICE, INBRED C3H; SPLEEN;

EID: 0033967255     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315206     Document Type: Article

References (16)

1. 1. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytic ehrlichial species as the etiologic agent of human disease. J Clin Microbiol 1994; 32:589-95.
2. 2. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995; 20:1102-10.
3. 3. Bakken JS, Krueth JK, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199-205.
4. 4. Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996; 2:18-29.
5. 5. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis (HGE): a series from a single medical center in New York State. Ann Intern Med 1996; 125:904-8.
6. 6. Wong S. Grady LJ. Ehrlichia infection as a cause of severe respiratory distress [letter]. N Engl J Med 1996; 334:273.
7. 7. Bakken JS, Goellner P, Van Etten M, et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis 1998; 27:1491-6.
8. 8. Walker DH, Dumler JS. Human monocytic and granulocytic ehrlichioses: discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med 1997; 121:785-91.
9. 9. Madigan JE, Richter PJ, Kimsey RB, Barlough JE, Bakken JS, Dumler JS. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis 1995; 172:1141-4.
10. 10. Telford SR III, Dawson JE, Katavolos P, Warner CK, Kolbert CP, Persing DH. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci USA 1996; 93:6209-14.
11. 11. Hodzic E, Ijdo JW, Feng S. et al. Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis 1998; 177:737-45.
12. 12. Bunnell JE, Trigiani ER, Srinivas S, Dumler JS. Development and distribution of pathologic lesions are related to immune status and tissue deposition of HGE agent-infected cells in a murine model system. J Infect Dis 1999; 180:546-50.
13. 13. Asanovich KM, Bakken JS, Madigan JE, Aguero-Rosenfeld M, Wormser GP, Dumler JS. Antigenic diversity of granulocytic Ehrlichia species isolates from humans in Wisconsin, New York, and a California horse. J Infect Dis 1997; 176:1029-34.
14. 14. Bunnell JE, Dumler JS, Childs JE, Glass GE. Retrospective serosurvey for antibodies reactive to the HGE agent in Peromyscus leucopus from Baltimore, Maryland. J Wildl Dis 1998; 34:179-81.
15. 15. Sun W, Ijdo JW, Telford SR III, et al. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest 1997; 100:3014-8.
16. 16. Dumler JS, Trigiani ER, Bakken JS, Aguero-Rosenfeld ME, Wormser GP. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin Diagn Lab Immunol (in press).